Daidzein analogs as treatment for cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9669004
SERIAL NO

14597252

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are compositions for treatment of cancers, including breast cancer, comprising at least one novel daidzein analog, as well as methods of using the same for preventing or treating cancer or tumor growth.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND1430 TULANE AVE TB-32 NEW ORLEANS LA 70112-2632
UNITED STATES DEPARTMENT OF AGRICULTUREWASHINGTON DC
XAVIER UNIVERSITY OF LOUISIANA1 DREXEL DRIVE BOX 68 OFFICE OF RESEARCH AND SPONSORED PROGRAMS NEW ORLEANS LA 70125-1098

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boue, Stephen M New Orleans, US 10 25
Burow, Matthew E New Orleans, US 20 20
Jiang, Quan New Orleans, US 30 128
Wang, Guangdi New Orleans, US 15 13
Wiese, Thomas E New Orleans, US 3 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 6, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00